Southern Gazette (South Perth) - - STREET WATCH -

The Ther­a­peu­tic Goods Ad­min­is­tra­tion (TGA) urges con­sumers and health pro­fes­sion­als to re­port ad­verse events ex­pe­ri­enced in as­so­ci­a­tion with transvagi­nal meshes. From July 2012 to June 2016, the TGA re­ceived 99 ad­verse events re­ports in­volv­ing transvagi­nal meshes. The most fre­quently re­ported ad­verse events were pain and ero­sion. Ad­verse events as­so­ci­ated with meshes may in­clude: punc­tures or lac­er­a­tions of ves­sels, nerves, struc­tures or or­gans, in­clud­ing the blad­der, ure­thra or bowel; tran­si­tory lo­cal ir­ri­ta­tion at the wound site; mesh ex­tru­sion, ex­po­sure, or ero­sion into the vagina or other struc­tures or or­gans; acute and/or chronic pain; void­ing dys­func­tion; pain dur­ing in­ter­course; neu­ro­mus­cu­lar prob­lems in­clud­ing acute and/or chronic pain in the groin, thigh, leg, pelvic and/or ab­dom­i­nal area; re­cur­rence of in­con­ti­nence; bleed­ing in­clud­ing haem­or­rhage, or haematoma; mesh mi­gra­tion; and al­ler­gic re­ac­tion.

Sue Turner is one of many women in Aus­tralia ex­pe­ri­enc­ing health prob­lems fol­low­ing a transvagi­nal mesh im­plant.

Newspapers in English

Newspapers from Australia

© PressReader. All rights reserved.